Crexendo CTO sells 25,000 shares in open market

Crexendo, Inc. Chief Technology Officer David Tzat-kin Wang reported an open-market sale of 25,000 shares of Crexendo common stock at a price of $10.01 per share.

Accepted by SEC EDGAR 06/04/2026 - 09:06 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Crexendo, Inc. Chief Technology Officer David Tzat-kin Wang reported an open-market sale of 25,000 shares of Crexendo common stock at a price of $10.01 per share. After this transaction, he directly holds 604,949 shares of Crexendo common stock, indicating he retains a substantial equity position in the company.

Insider Trade Summary

Net Seller: 25,000 shares

Net Sell 1 txn

Insider Wang David Tzat-kin

Role Chief Technology Officer

Sold 25,000 shs ($250K)

Share of Position Sold 4.0%

Type	Security	Shares	Price	Value
Sale	Common Stock	25,000	$10.01	$250K

Holdings After Transaction: Common Stock — 604,949 shares (Direct)

Holdings Before and After: Common Stock, 629,949 to 604,949 shares (Direct)

Other Insiders: 6 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Key Figures

Shares sold: 25,000 shares Sale price: $10.01 per share Shares held after transaction: 604,949 shares +1 more

4 metrics

Shares sold 25,000 shares Open-market sale of Crexendo common stock

Sale price $10.01 per share Price for the 25,000 shares sold

Shares held after transaction 604,949 shares Direct ownership after the sale

Net share change 25,000 shares sold netBuySellShares from transaction summary

Key Terms

open-market sale, Common Stock, non-derivative, transaction code "S"

4 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

""transaction_type": "non-derivative""

transaction code "S" regulatory

""transaction_code": "S""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Crexendo (CXDO) report for David Tzat-kin Wang?

Crexendo reported that Chief Technology Officer David Tzat-kin Wang completed an open-market sale of 25,000 shares of the company’s common stock. The transaction involved non-derivative common shares and was disclosed in a Form 4 insider trading report filed with regulators.

How many Crexendo (CXDO) shares did the CTO sell and at what price?

The Chief Technology Officer sold 25,000 shares of Crexendo common stock at a price of $10.01 per share. This was an open-market sale of non-derivative common stock, as reflected in the Form 4 transaction details provided in the filing data.

How many Crexendo (CXDO) shares does the CTO hold after the reported sale?

Following the reported transaction, the Chief Technology Officer directly holds 604,949 shares of Crexendo common stock. This post-transaction figure reflects his remaining direct ownership position after selling 25,000 shares in the open market according to the Form 4 disclosure.

Was the Crexendo (CXDO) CTO’s transaction a buy or a sell?

The transaction was a sell. The Form 4 lists transaction code “S” and describes the action as an open-market sale, with 25,000 shares of Crexendo common stock sold and no derivative exercises or acquisitions reported in the provided transaction summary.

Did the Crexendo (CXDO) Form 4 include any derivative security exercises?

No derivative security exercises were included in this Form 4. The filing shows only a non-derivative transaction in common stock, with zero derivative transactions and zero exercise shares reported in the transaction summary and derivativeSummary fields.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wang David Tzat-kin

(Last)

(First)

(Middle)

1225 W WASHINGTON ST

STE 213

(Street)

TEMPE

ARIZONA

85288

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crexendo, Inc. [ CXDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/02/2026		S		25,000	D	$10.01	604,949	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ David Tzat-kin Wang	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR